Skip to main content

Market Overview

Johnson & Johnson (NYSE: JNJ)

170.43 +0.59 (0.35%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2022
Pre-Market
EPS:
REV:




Q4 2021
Pre-Market
EPS:
REV:




Q3 2021
Pre-Market
EPS:
REV:
2.2
21.082B



Q2 2021
Pre-Market
EPS:
REV:




Q1 2021
Pre-Market
EPS:
REV:
2.3
20.691B
2.34
22.01B
2.59
22.321B
10.68%
1.41%
Q4 2020
Pre-Market
EPS:
REV:
1.88
20.747B
1.82
21.67B
1.86
22.475B
2.2%
3.71%
Q3 2020
Pre-Market
EPS:
REV:
2.12
20.729B
1.98
20.2B
2.2
21.082B
11.11%
4.37%
Q2 2020
Pre-Market
EPS:
REV:
2.58
20.562B
1.48
17.5B
1.67
18.336B
12.84%
4.78%
Q1 2020
Pre-Market
EPS:
REV:
2.1
20.021B
1.99
19.44B
2.3
20.691B
15.58%
6.44%
Q4 2019
Pre-Market
EPS:
REV:
1.97
20.394B
1.87
20.78B
1.88
20.747B
0.53%
-0.16%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!